Literature DB >> 32354887

Expression of Periostin in Cancer-associated Fibroblasts in Mammary Cancer in Female Dogs.

Paulina Borecka1, Katarzyna Ratajczak-Wielgomas2, Rafal Ciaputa3, Małgorzata Kandefer-Gola3, Izabela Janus3, Aleksandra Piotrowska2, Alicja Kmiecik2, Marzena Podhorska-Okolów4, Piotr Dzięgiel2,5, Marcin Nowak3.   

Abstract

BACKGROUND/AIM: Mammary neoplasms, like breast neoplasms in women, are one of the most common tumours in female dogs. Cancer-associated fibroblasts (CAFs) found in the tumour stroma play a role in angiogenesis and increase cell migration, contributing to tumour growth and progression, as well as metastasis. The aim of our work was to determine the level of periostin (POSTN) expression in CAFs in mammary tumours of female dogs.
MATERIALS AND METHODS: The research material consisted of 77 carcinomas and 24 adenomas of the mammary ridge in female dogs. Immunohistochemistry tests were performed using antibodies directed against the antigens POSTN, Ki-67, ERB-B2 receptor tyrosine kinase 2 (HER2), vimentin, and alpha smooth muscle actin (αSMA). Expression of POSTN at the mRNA level was determined using real-time polymerase chain reaction methods in 20 cases of mammary neoplasms.
RESULTS: Expression of POSTN in CAFs was observed in 92% of mammary cancer samples and in 25% of mammary adenoma samples in female dogs. A statistically significant increase in POSNT expression in CAFs was found in the carcinomas compared with mammary adenomas in female dogs. Expression of POSTN in CAFs in mammary carcinomas in female dogs positively correlated with the histological malignancy grade of tumours and the expression of Ki-67 proliferative antigen.
CONCLUSION: Our results suggest a role of POSTN on the pathogenesis of mammary tumours in female dogs. Moreover, POSTN may prove to be a useful marker in the evaluation of cancerous stroma of mammary tumours in female dogs, and may have prognostic significance. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CAFs; POSTN; Periostin; adenoma; carcinoma; female dog; mammary tumour

Mesh:

Substances:

Year:  2020        PMID: 32354887      PMCID: PMC7279791          DOI: 10.21873/invivo.11870

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  42 in total

1.  Immunohistochemical and histochemical analysis of newly formed tissues in root canal space transplanted with dental pulp stem cells plus platelet-rich plasma.

Authors:  Xiaofei Zhu; Yu Wang; Yuan Liu; George T-J Huang; Chengfei Zhang
Journal:  J Endod       Date:  2014-07-09       Impact factor: 4.171

2.  Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.

Authors:  Bartosz Pula; Aleksandra Jethon; Aleksandra Piotrowska; Agnieszka Gomulkiewicz; Tomasz Owczarek; Jacek Calik; Andrzej Wojnar; Wojciech Witkiewicz; Janusz Rys; Maciej Ugorski; Piotr Dziegiel; Marzena Podhorska-Okolow
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

Review 3.  The role of periostin in neoplastic processes.

Authors:  Katarzyna Ratajczak-Wielgomas; Piotr Dziegiel
Journal:  Folia Histochem Cytobiol       Date:  2015-07-07       Impact factor: 1.698

4.  Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I.

Authors:  S Takeshita; R Kikuno; K Tezuka; E Amann
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

Review 5.  Canine mammary gland tumors.

Authors:  Karin Sorenmo
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-05       Impact factor: 2.093

6.  Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer.

Authors:  Marta Vascellari; Katia Capello; Antonio Carminato; Claudia Zanardello; Elisa Baioni; Franco Mutinelli
Journal:  Prev Vet Med       Date:  2016-03-03       Impact factor: 2.670

7.  Relationship between the inflammatory tumor microenvironment and different histologic types of canine mammary tumors.

Authors:  Thiago Alves de Souza; Cecília Bonolo de Campos; Aline De Biasi Bassani Gonçalves; Fernanda Camargo Nunes; Lidianne Narducci Monteiro; Rosemeri de Oliveira Vasconcelos; Geovanni Dantas Cassali
Journal:  Res Vet Sci       Date:  2018-06-23       Impact factor: 2.534

8.  The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.

Authors:  P V Nuzzo; A Rubagotti; L Zinoli; S Salvi; S Boccardo; F Boccardo
Journal:  BMC Cancer       Date:  2016-02-12       Impact factor: 4.430

9.  Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Authors:  Andreia A Santos; Célia C Lopes; Jorge R Ribeiro; Liliana R Martins; Joana C Santos; Irina F Amorim; Fátima Gärtner; Augusto J Matos
Journal:  BMC Vet Res       Date:  2013-01-04       Impact factor: 2.741

10.  Overexpression of periostin predicts poor prognosis in non-small cell lung cancer.

Authors:  Ling-Zhi Hong; Xiao-Wei Wei; Jin-Fei Chen; Yi Shi
Journal:  Oncol Lett       Date:  2013-09-18       Impact factor: 2.967

View more
  3 in total

1.  Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells in Cavernous Hemangioma.

Authors:  Fulong Ji; Yong Liu; Jinsong Shi; Chunxiang Liu; Siqi Fu; Heng Wang; Bingbing Ren; Dong Mi; Shan Gao; Daqing Sun
Journal:  Front Cell Dev Biol       Date:  2022-07-05

2.  Expression of Periostin in Mammary Cancer Cells of Female Dogs.

Authors:  Paulina Borecka; Rafal Ciaputa; Izabela Janus; Joanna Bubak; Aleksandra Piotrowska; Katarzyna Ratajczak-Wielgomas; Marzenna Podhorska-OkolÓw; Piotr DziĘgiel; Marcin Nowak
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 3.  The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors.

Authors:  Adrian Wasik; Katarzyna Ratajczak-Wielgomas; Arkadiusz Badzinski; Piotr Dziegiel; Marzenna Podhorska-Okolow
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.